HeartShare
An innovative new heart failure study funded by
the US National Institutes of Health that uses next-generation phenomics to define heart failure subtypes and treatment targets
HeartShare is an innovative new program funded by the National Heart, Lung, and Blood Institute (NHLBI) of the US National Institutes of Health (NIH). HeartShare combines deep phenotyping, multi-omics, electronic health records, and machine learning to identify heart failure subtypes and treatment targets.
HeartShare is a new study that aims to enroll 1,000 participants across 6 clinical centers in the US.
HeartShare is a new resource for the study of heart failure and is open to research collaborations for investigators.